Rituxan Hycela
Generic: rituximab and hyaluronidase
- Manufacturer
- Genentech
- NDC
- 50242-108
- RxCUI
- 1927885
- Route
- SUBCUTANEOUS
- ICD-10 indication
- C83.30
Affordability Check
How much will you actually pay for Rituxan Hycela?
In 30 seconds, see every legitimate way to afford Rituxan Hycela — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Rituxan Hycela
What is this medication? Rituxan Hycela is a prescription medication that combines rituximab and hyaluronidase human to treat specific types of non-Hodgkin lymphoma and chronic lymphocytic leukemia in adults. It is indicated for patients with follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia who have already received at least one full dose of intravenous rituximab. Unlike traditional intravenous treatments, this version is administered as an injection under the skin, which significantly reduces the time required for each treatment session.
The medication works through the action of rituximab, a monoclonal antibody that targets the CD20 protein on the surface of certain white blood cells known as B-cells. Once attached, it helps the immune system identify and destroy these cells. The hyaluronidase human component acts as an enzyme that temporarily breaks down barriers in the tissue, allowing the rituximab to be absorbed into the bloodstream. This combination allows for a more convenient administration while maintaining the therapeutic effects of the antibody treatment.
Copay & patient assistance
- Patient Copay Amount: Eligible patients may pay as little as $0 per treatment.
- Maximum Annual Benefit Limit: Up to $25,000 per calendar year.
- Core Eligibility Restrictions: Patients must have commercial (private) insurance and a prescription for an FDA-approved indication. The program is not available to those using federal or state-funded healthcare plans, including Medicare, Medicaid, and TRICARE. Patients must be 18 years of age or older (or have a legal guardian 18+), reside and receive treatment in the U.S. or U.S. Territories, and not be receiving concurrent assistance from the Genentech Patient Foundation or other charitable organizations for the same expenses.
- RxBIN, PCN, and Group numbers: Not Publicly Available.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for rituximab and hyaluronidase.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Rituxan Hycela →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for rituximab and hyaluronidase →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
AVGEMSI
Treats same condition · Gemcitabine
Xospata
Treats same condition · gilteritinib
JYLAMVO
Treats same condition · Methotrexate
Mercaptopurine
Treats same condition · Mercaptopurine
Xalkori
Treats same condition · CRIZOTINIB
Elliotts B
Treats same condition · sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate
PADCEV EJFV
Treats same condition · ENFORTUMAB VEDOTIN
Mitoxantrone
Treats same condition · Mitoxantrone
Ondansetron Hydrochloride
Treats same condition · Ondansetron Hydrochloride
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
Treats same condition · Paclitaxel
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
Rituxan Hycela treats 4 rare conditions. For in-depth disease pages on our sister site:
- UniteRare · Lymphoma
- UniteRare · Diffuse Large B-cell Lymphoma
- UniteRare · Follicular Lymphoma
- UniteRare · Chronic Lymphocytic Leukemia
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.